Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Asset Writedowns and Impairment (2016 - 2018)

Ironwood Pharmaceuticals' Asset Writedowns and Impairment history spans 4 years, with the latest figure at $151.8 million for Q3 2018.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $151.8 million in Q3 2018 year-over-year; TTM through Sep 2019 was $153.6 million, a 0.0% change, with the full-year FY2018 number at $151.8 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment hit $151.8 million in Q3 2018 for Ironwood Pharmaceuticals, up from $1.8 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for IRWD hit a ceiling of $151.8 million in Q3 2018 and a floor of $1.8 million in Q2 2018.
  • Historically, Asset Writedowns and Impairment has averaged $31.5 million across 4 years, with a median of $9.5 million in 2014.
  • The widest YoY moves for Asset Writedowns and Impairment: up 43.82% in 2015, down 43.82% in 2015.
  • Tracing IRWD's Asset Writedowns and Impairment over 4 years: stood at $11.4 million in 2014, then tumbled by 56.14% to $5.0 million in 2015, then surged by 102.0% to $10.1 million in 2016, then skyrocketed by 1402.91% to $151.8 million in 2018.
  • Business Quant data shows Asset Writedowns and Impairment for IRWD at $151.8 million in Q3 2018, $1.8 million in Q2 2018, and $10.1 million in Q4 2016.